1. Home
  2. AURA vs EHAB Comparison

AURA vs EHAB Comparison

Compare AURA & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • EHAB
  • Stock Information
  • Founded
  • AURA 2007
  • EHAB 2014
  • Country
  • AURA United States
  • EHAB United States
  • Employees
  • AURA N/A
  • EHAB N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • EHAB Hospital/Nursing Management
  • Sector
  • AURA Health Care
  • EHAB Health Care
  • Exchange
  • AURA Nasdaq
  • EHAB Nasdaq
  • Market Cap
  • AURA 379.6M
  • EHAB 401.8M
  • IPO Year
  • AURA 2021
  • EHAB N/A
  • Fundamental
  • Price
  • AURA $7.77
  • EHAB $7.98
  • Analyst Decision
  • AURA Strong Buy
  • EHAB Hold
  • Analyst Count
  • AURA 4
  • EHAB 6
  • Target Price
  • AURA $23.00
  • EHAB $9.20
  • AVG Volume (30 Days)
  • AURA 162.1K
  • EHAB 285.2K
  • Earning Date
  • AURA 11-12-2024
  • EHAB 03-05-2025
  • Dividend Yield
  • AURA N/A
  • EHAB N/A
  • EPS Growth
  • AURA N/A
  • EHAB N/A
  • EPS
  • AURA N/A
  • EHAB N/A
  • Revenue
  • AURA N/A
  • EHAB $1,037,200,000.00
  • Revenue This Year
  • AURA N/A
  • EHAB $0.93
  • Revenue Next Year
  • AURA N/A
  • EHAB $3.50
  • P/E Ratio
  • AURA N/A
  • EHAB N/A
  • Revenue Growth
  • AURA N/A
  • EHAB N/A
  • 52 Week Low
  • AURA $6.63
  • EHAB $6.85
  • 52 Week High
  • AURA $12.38
  • EHAB $11.74
  • Technical
  • Relative Strength Index (RSI)
  • AURA 39.85
  • EHAB 55.09
  • Support Level
  • AURA $7.46
  • EHAB $7.51
  • Resistance Level
  • AURA $7.90
  • EHAB $7.80
  • Average True Range (ATR)
  • AURA 0.30
  • EHAB 0.28
  • MACD
  • AURA -0.00
  • EHAB 0.02
  • Stochastic Oscillator
  • AURA 34.65
  • EHAB 83.19

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About EHAB Enhabit Inc.

Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health segment include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates the majority of its revenue from the Home Health segment.

Share on Social Networks: